Currently, the breast oncology field mainly classifies BC into four fixed biological subtypes: luminal A (ER+/HER2-/grade 1 or grade 2), luminal B (ER+/HER2-/grade 3), HER2 rich (any HER2+ tumor), and basal-like (ER-/PR-/HER2-). Here, ERBB2 is linked to breast cancer.